Patent · US Active

Immortalized avian cell lines for virus production

US8940534B2 · kind B2 · utility

6Cited by

6References

17Claims

0Family size

Assignee

ProBioGen AG · DE

Inventors

Volker Sandig · Berlin, DE
Ingo Jordan · Berlin, DE

Key dates

Filing date	Nov 3, 2004
Grant date	Jan 27, 2015
Priority date	—
Expiry date	Nov 7, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/24122
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to immortalized avian cell lines suitable for production of biologicals or viruses for vaccination. In particular, the cell lines are derived from primary cells which are transformed with at least two viral or cellular genes, one of which causes cell cycle progression whereas the other interferes with innate protective mechanisms of the cell induced by dysregulated replication. The invention moreover relates to the production of said immortalized cell lines and their use for producing biologicals or viruses for vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.